These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10201944)

  • 1. Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition.
    Wang H; Eckels DD
    J Immunol; 1999 Apr; 162(7):4177-83. PubMed ID: 10201944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
    Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P
    Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.
    Harcourt GC; Lucas M; Sheridan I; Barnes E; Phillips R; Klenerman P
    J Viral Hepat; 2004 Jul; 11(4):324-31. PubMed ID: 15230855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
    Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence variation in the gene encoding the nonstructural 3 protein of hepatitis C virus: evidence for immune selection.
    Wang H; Bian T; Merrill SJ; Eckels DD
    J Mol Evol; 2002 Apr; 54(4):465-73. PubMed ID: 11956685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
    Fytili P; Dalekos GN; Schlaphoff V; Suneetha PV; Sarrazin C; Zauner W; Zachou K; Berg T; Manns MP; Klade CS; Cornberg M; Wedemeyer H
    Vaccine; 2008 Jul; 26(31):3818-26. PubMed ID: 18582999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.
    Gerlach JT; Ulsenheimer A; Grüner NH; Jung MC; Schraut W; Schirren CA; Heeg M; Scholz S; Witter K; Zahn R; Vogler A; Zachoval R; Pape GR; Diepolder HM
    J Virol; 2005 Oct; 79(19):12425-33. PubMed ID: 16160170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients.
    Godkin A; Jeanguet N; Thursz M; Openshaw P; Thomas H
    Eur J Immunol; 2001 May; 31(5):1438-46. PubMed ID: 11465100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between helper T-cell epitopes of hepatitis C virus.
    Zhu F; Yang M; Eckels DD
    Vaccine; 2005 May; 23(27):3572-80. PubMed ID: 15855016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus mutation affects proteasomal epitope processing.
    Seifert U; Liermann H; Racanelli V; Halenius A; Wiese M; Wedemeyer H; Ruppert T; Rispeter K; Henklein P; Sijts A; Hengel H; Kloetzel PM; Rehermann B
    J Clin Invest; 2004 Jul; 114(2):250-9. PubMed ID: 15254592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
    Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
    J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
    Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
    Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins.
    Sarobe P; Lasarte JJ; García N; Civeira MP; Borrás-Cuesta F; Prieto J
    J Viral Hepat; 2006 Jan; 13(1):47-55. PubMed ID: 16364082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.
    Penna A; Missale G; Lamonaca V; Pilli M; Mori C; Zanelli P; Cavalli A; Elia G; Ferrari C
    Hepatology; 2002 May; 35(5):1225-36. PubMed ID: 11981773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.
    Castelli FA; Leleu M; Pouvelle-Moratille S; Farci S; Zarour HM; Andrieu M; Auriault C; Ménez A; Georges B; Maillere B
    Eur J Immunol; 2007 Jun; 37(6):1513-23. PubMed ID: 17492804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase.
    Jolivet-Reynaud C; Adida A; Michel S; Deléage G; Paranhos-Baccala G; Gonin V; Battail-Poirot N; Lacoux X; Rolland D
    J Med Virol; 2004 Mar; 72(3):385-95. PubMed ID: 14748062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
    Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
    J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice.
    Barfoed AM; Rodriguez F; Therrien D; Borrego B; Sobrino F; Kamstrup S
    Antiviral Res; 2006 Dec; 72(3):178-89. PubMed ID: 16890298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.